Form 4: SOPHiA GENETICS SA Executive Sells Shares
Insider Transaction (Form 4)
Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 20,000 shares of common stock on August 5, 2026.
Summary
- Option exercise/conversion: acquired 3,000 Ordinary Shares at $3.28 ($9,840) on August 5, 2026; holds 603,887 after (Direct).
- Open-market sale: disposed of 3,000 Ordinary Shares at $7.00 ($21,013) on August 5, 2026; holds 600,887 after (Direct).
- Option exercise/conversion: acquired 7,000 Ordinary Shares at $3.28 ($22,960) on August 7, 2026; holds 607,887 after (Direct).
- Open-market sale: disposed of 7,000 Ordinary Shares at $7.02 ($49,152) on August 7, 2026; holds 600,887 after (Direct).
- Open-market sale: disposed of 10,000 Ordinary Shares at $7.48 ($74,759) on August 7, 2026; holds 590,887 after (Direct).
- Option exercise/conversion: disposed of 3,000 Share Option (Right to Buy) at $3.28 ($9,840) on August 5, 2026; holds 7,000 after (Direct).
- Option exercise/conversion: disposed of 7,000 Share Option (Right to Buy) at $3.28 ($22,960) on August 7, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $144,924 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Zhenyu Xu — Officer (Chief Scientific Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Option exercise/conversion | Ordinary Shares | 3,000 | $3 | $9.8K | 603,887 |
| 2026-08-05 | Open-market sale | Ordinary Shares | 3,000 | $7 | $21.0K | 600,887 |
| 2026-08-07 | Option exercise/conversion | Ordinary Shares | 7,000 | $3 | $23.0K | 607,887 |
| 2026-08-07 | Open-market sale | Ordinary Shares | 7,000 | $7 | $49.2K | 600,887 |
| 2026-08-07 | Open-market sale | Ordinary Shares | 10,000 | $7 | $74.8K | 590,887 |
| 2026-08-05 | Option exercise/conversion | Share Option (Right to Buy) | 3,000 | $3 | $9.8K | 7,000 |
| 2026-08-07 | Option exercise/conversion | Share Option (Right to Buy) | 7,000 | $3 | $23.0K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Option exercise/conversion (3,000 shares) |
| 2026-08-05 | Open-market sale (3,000 shares) |
| 2026-08-07 | Option exercise/conversion (7,000 shares) |
| 2026-08-07 | Open-market sale (7,000 shares) |
| 2026-08-07 | Open-market sale (10,000 shares) |
| 2026-08-05 | Option exercise/conversion (3,000 shares) |
| 2026-08-07 | Option exercise/conversion (7,000 shares) |
Keywords
insider transaction, Form 4, SOPH, SOPHiA GENETICS SA, bearish, Zhenyu Xu
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.